Theralase Technologies (TLTFF) has a profit margin of -472.48%, below the sector sector average of 13.09%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for TLTFF is -472.48% as of June 2026. That compares with -400.66% in the prior-year period — down 17.9% year over year. That is below the sector sector average of 13.09%. Investors often review this figure alongside Theralase Technologies's historical trend and sector peers before judging valuation or financial health.
Over the past year, TLTFF's profit margin moved from -400.66% to -472.48% — a 17.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Theralase Technologies's valuation or profitability profile.
Against its sector companies, TLTFF currently prints -472.48% for profit margin, while the sector average sits near 13.09%. That is roughly 3709.9% below the sector mean. Large gaps often invite a closer look at Theralase Technologies's growth, margins, and balance sheet.
Profit Margin shows how effectively Theralase Technologies converts resources into returns. At -472.48%, TLTFF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -400.66% in the prior-year period — down 17.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting TLTFF's profit margin (-472.48%), review year-over-year change from -400.66%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.